Zoledronic acid
0,8 mg/ml, 5 ml № 1, № 5, № 10
Group of action
Active ingredient
Dosage form
Concentrate for solution for infusion
ATC code
М05ВА08
RX/OTC
RX
Marketing authorisation no.
UA/16730/01/01
General properties
Pharmacotherapeutic group
Means affecting the structure and mineralization of bones. Bisphosphonates.
Indications
- Prevention of symptoms associated with damage to the bone tissue (pathological fractures, compression of the spinal trunk, complications after surgical interventions and radiation therapy, or hypercalcemia caused by a malignant tumor) in patients with malignant tumors in the later stages.
- Treatment of hypercalcemia caused by a malignant tumor.
Contraindications
Hypersensitivity to the active ingredient (Zoledronic acid), other bisphosphonates, or any excipients in the drug composition.
Pregnancy and lactation.
Pharmaceutical characteristics
Basic physical and chemical properties
Transparent colorless liquid.
Shelf life
2 years.
Storage conditions
Store in original packaging at a temperature not higher than 25 °C. Keep out of the reach of children.
Manufacturer
PJSC "Lekhim-Kharkiv".
Location
36, Severyna Pototskoho St., 61115 Kharkiv, Ukraine.
